+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Addiction Disorders Drugs Market Research Reports

Substance Use Disorder (SUD) - Pipeline Insight, 2024 - Product Thumbnail Image

Substance Use Disorder (SUD) - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Smoking Cessation and Nicotine Deaddiction - Pipeline Insight, 2024 - Product Thumbnail Image

Smoking Cessation and Nicotine Deaddiction - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Non-Opioid Strontium Chloride - Pipeline Insight, 2024 - Product Thumbnail Image

Non-Opioid Strontium Chloride - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Opioid Overdose - Pipeline Insight, 2024 - Product Thumbnail Image

Opioid Overdose - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Cocaine Use Disorder - Pipeline Insight, 2024 - Product Thumbnail Image

Cocaine Use Disorder - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Opioid Receptor Agonists - Pipeline Insight, 2024 - Product Thumbnail Image

Opioid Receptor Agonists - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 90 Pages
  • Global
From
Delta Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Delta Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Mu Antagonist - Pipeline Insight, 2024 - Product Thumbnail Image

Mu Antagonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Opioid kappa receptor agonists - Pipeline Insight, 2024 - Product Thumbnail Image

Opioid kappa receptor agonists - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Nociceptin receptor agonists - Pipeline Insight, 2024 - Product Thumbnail Image

Nociceptin receptor agonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Opioid mu receptor antagonists - Pipeline Insight, 2024 - Product Thumbnail Image

Opioid mu receptor antagonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
Global Alexipharmic Drugs Market by Application, by Route of Administration, by End-Users, and By Region - Product Thumbnail Image

Global Alexipharmic Drugs Market by Application, by Route of Administration, by End-Users, and By Region

  • Report
  • March 2024
  • 200 Pages
  • Global
From
Global Substance Abuse Disorder Treatment Market Analysis & Forecast 2024-2034: Market By Treatment; By End-user; and By Region - Product Thumbnail Image

Global Substance Abuse Disorder Treatment Market Analysis & Forecast 2024-2034: Market By Treatment; By End-user; and By Region

  • Report
  • October 2023
  • 145 Pages
  • Global
From
Global Opioid Use Disorder Market Analysis & Forecast 2024-2034: Market By Drug; By Age Group; By Route of Administration; By Distribution Channel; and By Region - Product Thumbnail Image

Global Opioid Use Disorder Market Analysis & Forecast 2024-2034: Market By Drug; By Age Group; By Route of Administration; By Distribution Channel; and By Region

  • Report
  • October 2023
  • 145 Pages
  • Global
From
Opioid Use Disorder Market Forecasts from 2023 to 2028 - Product Thumbnail Image

Opioid Use Disorder Market Forecasts from 2023 to 2028

  • Report
  • November 2023
  • 140 Pages
  • Global
From
Global Nicotine Patch Market 2024-2028 - Product Thumbnail Image

Global Nicotine Patch Market 2024-2028

  • Report
  • February 2024
  • 160 Pages
  • Global
From
Global Nicotine Gum Market 2023-2027 - Product Thumbnail Image

Global Nicotine Gum Market 2023-2027

  • Report
  • June 2023
  • 163 Pages
  • Global
From
Alcohol Use Disorder (AUD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Alcohol Use Disorder (AUD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • July 2023
  • 70 Pages
  • Global
From
Fetal Alcohol Spectrum Disorder Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Fetal Alcohol Spectrum Disorder Treatment Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • May 2023
  • 96 Pages
  • Global
From
Nicotine Gum Market: Industry Size, Share, Competition, Trends, Growth Opportunities and Forecasts by Region - Insights and Outlook by Product, 2024 to 2031 - Product Thumbnail Image

Nicotine Gum Market: Industry Size, Share, Competition, Trends, Growth Opportunities and Forecasts by Region - Insights and Outlook by Product, 2024 to 2031

  • Report
  • January 2024
  • 156 Pages
  • Global
From
Loading Indicator

The Addiction Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and sale of drugs used to treat addiction disorders. These drugs are used to treat a variety of conditions, including alcohol and drug addiction, nicotine addiction, and gambling addiction. The market is composed of both generic and branded drugs, with the latter being more expensive. The market is highly competitive, with many companies vying for market share. Companies in the market include Pfizer, GlaxoSmithKline, Johnson & Johnson, Novartis, and Sanofi. These companies are constantly researching and developing new drugs to treat addiction disorders, as well as improving existing treatments. Additionally, many of these companies are involved in clinical trials to test the efficacy of their drugs. Show Less Read more